| Literature DB >> 33011214 |
Rebecca Fish1, Steven MacLennan2, Bilal Alkhaffaf3, Paula R Williamson4.
Abstract
OBJECTIVE: The objectives of this nested study were to (1) assess whether changes in scores between rounds altered the final degree of consensus achieved in three Delphi surveys conducted as part of COS development projects (anal, gastric, and prostate cancer), and (2) explore participants' reasons for changing scores between rounds. STUDY DESIGN ANDEntities:
Keywords: Core outcome set development; Delphi survey; Feedback methods; Stakeholders; consensus; patient public involvement
Mesh:
Year: 2020 PMID: 33011214 PMCID: PMC7716748 DOI: 10.1016/j.jclinepi.2020.09.028
Source DB: PubMed Journal: J Clin Epidemiol ISSN: 0895-4356 Impact factor: 6.437
Fig. 1Schematic representation of how consensus is reached through a Delphi survey.
Scope and methodology of core outcome set projects
| Element | CORMAC | GASTROS | COMPACTERS |
|---|---|---|---|
| Health condition | Squamous cell carcinoma of the anus/anal canal | Cancer of the stomach | Localized prostate cancer |
| Setting | Later phase clinical effectiveness trials that will inform clinical decision making | Later phase clinical effectiveness trials that will inform clinical decision making | Later phase clinical effectiveness trials that will inform clinical decision making |
| Population | Adults >18 years of age | Adults >18 years of age | Men >18 years of age |
| Types of intervention | Primary treatment with radiotherapy with or without concurrent chemotherapy | Surgery – total or partial gastrectomy | All primary treatments including active surveillance, watchful waiting, surgery, radiotherapy, brachytherapy, cryotherapy, high intensity focused ultrasound, and adjuvant hormonal therapy |
| Development steps | Systematic review; patient interviews; online e-Delphi; face-to-face consensus meeting | Systematic review; patient interviews; online e-Delphi; face-to-face consensus meeting | Systematic review; patient interviews, online e-Delphi; face-to-face consensus meeting |
Delphi survey characteristics
| Characteristic | CORMAC | GASTROS | COMPACTERS |
|---|---|---|---|
| Languages | English | English, Chinese, Dutch, German, Italian, Portuguese, Spanish, Turkish | English |
| Participants counties of residence | Australia, Canada, France, Netherlands, New Zealand, Norway, Spain, Sweden, UK and Ireland, USA | Argentina, Australia, Austria, Azerbaijan, Belgium, Brazil, Cameroon, Canada, Chile, China, Colombia, Costa Rica, Czech Republic, Denmark, Ecuador, Egypt, Finland, Greece, Hong Kong, Hungary, India, Iran, Ireland, Italy, Japan, Jordan, Kenya, Luxembourg, Malaysia, Mexico, Mongolia, Morocco, Netherlands, New Zealand, Nigeria, Pakistan, Peru, Poland, Portugal, Romania, Russia, Saudi Arabia, Serbia, Singapore, South Korea, Sudan, Sweden, Switzerland, Taiwan, Thailand, Turkey, UK, Ukraine, USA, Vietnam | France, Germany, Italy, Netherlands, UK, USA |
| N participants completing R1; R2 | Patients: 73; 54 | Patients: 268, 184 | Patients: 118; 109 |
| Types of HCP completing R1 and R2 | Surgeon (coloproctologists) 36 (38%) | Surgeons (esophago-gastric): 343 (71%) | Surgeons (urologist): 33 (68%) |
| Delphi timeline | April 2017– September 2017 | March 2019- October 2019 | November 2014 – July 2015 |
| Attrition rate R1-R2 | Patients: 26.0% | Patients: 31.1% | Patients: 7.6% |
| Total number of outcomes scored in R1 | 73 | 56 | 79 |
| Number of outcomes reaching consensus in R1 | 12 | 11 | 9 |
| Number of additional outcomes added to R2 | 5 | 1 | 5 |
| Number of outcomes reaching consensus in R2; of which n additional outcomes | 14; 1 | 13; 0 | 13; 0 |
| N (%) of people changing score for at least one outcome | Patients: 52 (96.2%) | Patients: 147 (79.9%) | Patients: 102 (93.6%) |
| N (%) of people crossing a threshold for at least one outcome | Patients: 46 (85.1%) | Patients: 129 (70.1%) | Patients: 77 (75.5%) |
| N (%) of eligible participants providing at least 1 reason for change | Patients: 28 (61%) | Patients: 74 (40.2%) | Patients: 77 (75%) |
| Median and range of number of outcomes with threshold change for those who had at least one such change | Patients: 10.5 [1–16] | Patients: 8 [1–33] | Patients: 9 [2-49] |
Fig. 2Screenshots from round 2 of the CORMAC (A), GASTROS (B), and COMPACTERS (C) Delphi surveys showing how participants were shown the summarized results from round 1.
Fig. 3Coding framework showing the relationship of major themes (“parent codes”) and their related subthemes (“child codes”).
Reasons for change
| Theme | CORMAC | GASTROS | COMPACTERS | Total number of responses | Total % of responses | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HCP | Patient | HCP | Patient | HCP | Patient | |||||||||
| Number of responses | % Of responses | Number of responses | % Of responses | Number of responses | % Of responses | Number of responses | % Of responses | Number of responses | % Of responses | Number of responses | % Of responses | |||
| Time to reflect | 69 | 21% | 9 | 5% | 226 | 22% | 144 | 31% | 4 | 22% | 30 | 42% | 482 | 23% |
| Vicarious thinking | 160 | 48% | 21 | 13% | 187 | 18% | 30 | 6% | 12 | 67% | 15 | 21% | 424 | 21% |
| Impact | 40 | 12% | 47 | 28% | 228 | 23% | 76 | 16% | 1 | 6% | 2 | 3% | 394 | 19% |
| Importance | 29 | 9% | 11 | 7% | 186 | 18% | 85 | 18% | 0 | 0% | 0 | 0% | 311 | 15% |
| Specificity/usefulness | 26 | 8% | 17 | 10% | 129 | 13% | 37 | 8% | 1 | 6% | 1 | 1% | 211 | 10% |
| Personal experience | 0 | 0% | 47 | 28% | 0 | 0% | 92 | 20% | 0 | 0% | 16 | 22% | 156 | 8% |
| Understand the survey/question differently | 0 | 0% | 1 | 1% | 34 | 3% | 1 | 0% | 0 | 0% | 7 | 10% | 43 | 2% |
| Error in previous round | 3 | 1% | 4 | 2% | 10 | 1% | 1 | 0% | 0 | 0% | 0 | 0% | 18 | 1% |
| How | 3 | 1% | 0 | 0% | 10 | 1% | 0% | 0 | 0% | 0 | 0% | 13 | 1% | |
| Outcome not relevant to me | 0% | 6 | 4% | 1 | 0% | 3 | 1% | 0 | 0% | 1 | 1% | 11 | 1% | |
| Covered by another item | 2 | 1% | 3 | 2% | 0 | 0% | 0% | 0 | 0% | 0 | 0% | 5 | 0% | |
Most frequent reasons given
| Rank | CORMAC | GASTROS | COMPACTERS | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HCP | Patient | HCP | Patient | HCP | Patient | |||||||
| Code | % (n) of responses | Code | % (n) of responses | Code | % (n) of responses | Code | % (n) of responses | Code | % (n) of responses | Code | % (n) of responses | |
| 1 | Vicarious thinking | 48 (160) | Personal experience | 28 (47) | Impact | 23 (228) | Time to reflect | 31 (144) | Vicarious thinking | 67 (12) | Time to reflect | 42 (30) |
| 2 | Time to reflect | 21 (69) | Impact | 28 (47) | Time to reflect | 22 (226) | Personal experience | 20 (92) | Time to reflect | 22 (4) | Personal experience | 22 (16) |
| 3 | Impact | 12 (40) | Vicarious thinking | 13 (21) | Vicarious thinking | 18 (187) | Importance | 18 (85) | Impact; specificity/usefulness | 6 (1) | Vicarious thinking | 21 (15) |
Vicarious thinking as reason for change in score
| Subtheme | CORMAC | GASTROS | COMPACTERS | Total number of responses | Total % of responses | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HCP | Patient | HCP | Patient | HCP | Patient | |||||||||
| Number of responses | % Of responses | Number of responses | % Of responses | Number of responses | % Of responses | Number of responses | % Of responses | Number of responses | % Of responses | Number of responses | % Of responses | |||
| Others’ scores influenced me | 128 | 80% | 3 | 14% | 109 | 58% | 30 | 100% | 10 | 83% | 11 | 73% | 291 | 68% |
| | ||||||||||||||
| | ||||||||||||||
| | ||||||||||||||
| Meeting/hearing from/observing patients | 1 | 1% | 8 | 38% | 69 | 37% | 0 | 0% | 0 | 0% | 1 | 7% | 79 | 19% |
| Vicarious thinking- not further specified | 31 | 19% | 10 | 48% | 6 | 3% | 0 | 0% | 1 | 8% | 3 | 20% | 51 | 12% |
| Through education | 0 | 0% | 0 | 0% | 3 | 2% | 0 | 0% | 1 | 8% | 0 | 0% | 4 | 1% |